Literature DB >> 29954277

Workplace violence prevention standardization using lean principles across a healthcare network.

Scott A Hutton1, Kelly Vance2, Jesse Burgard3, Susan Grace4, Lynn Van Male1.   

Abstract

Purpose The purpose of this paper is to describe the process used to standardize a Workplace Violence Prevention Program (WVPP) within a five-hospital healthcare system in Veterans Health Administration (VHA). Design/methodology/approach A description of the lean process improvement principles, used to bring the WVPP into compliance with Occupational Safety and Health Administration (OSHA) and other agencies through streamlining/standardizing processes. Findings There was significant standardization in both the threat assessment and education arms of the WVPP. Compliance with all major US Department of Labor OSHA requirements, as well as substantial time savings, were realized as part of this process improvement. Originality/value VHA is leading the way in inter/multidisciplinary assessment and mitigation of workplace violence, however, there are significant competing demands on staff time. This first ever use of lean principles to streamline processes around workplace violence prevention freed up clinician time for care while improving internal and external customer satisfaction, representing a major step forward in workplace violence risk mitigation.

Entities:  

Keywords:  Health and safety; Lean thinking; Medicine; PDSA; Six sigma

Mesh:

Year:  2018        PMID: 29954277     DOI: 10.1108/IJHCQA-05-2017-0085

Source DB:  PubMed          Journal:  Int J Health Care Qual Assur        ISSN: 0952-6862


  1 in total

1.  A combined behavioural economics- and simulation-based medical education to promote effectiveness among medical residents in coping with workplace violence in Northern China: a quasi-experimental study.

Authors:  Chao Liu; Weijing Liu; Mingli Jiao; Ye Li; Gangyu Zhang; Lifeng Wei; Shuang Zhou; Yuanheng Li; Zhuowa Sha; Yanhua Hao; Qunhong Wu
Journal:  BMC Public Health       Date:  2022-06-01       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.